P87, good questions. Here are few reasons, I think:
1. DNA sees its own shares as cheaper value than any short-term acquisition, and no acquisition is in sight (for a few months). DNA alluded to this (i.e. some acquisitions have been discussed, but they are waiting until better priced). This explanation has been used for other buybacks (e.g. TIX in April 2014). Remember, too, that DNA doesn't need to spend all the buyback money and it can stop the buyback at any time when a good acquisition comes along. So remaining buyback funds can be quickly channeled into an acquisition.
2. DNA has solidly positive cash flow (quite clearly stated in its announcements/reports), so it has "extra" cash for a buyback. Better use of capital than letting it sit in aback account. Also, too early in DNA's development to start doing dividends, so a buyback is an effective alternative form of shareholder-friendly capital management. Even if DNA contemplated dividends (which it shouldn't for a while), with no franking (overseas business), a share buyback is apparently a better strategy.
3. It's a credibility thing. DNA's sp dropped far below the recent cap raise price. Even though instos are supposedly rational future-focused calculators, they may be reluctant to participate in future DNA cap raises if the sp doesn't recover quickly from the previous cap raising.
4. The MD and others have a major stake in DNA. Even though they have a long term view, they likely feel better if DNA's sp reflects its value and potential.
- Forums
- ASX - By Stock
- DNA
- Ann: Daily share buy-back notice
Ann: Daily share buy-back notice, page-36
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DNA (ASX) to my watchlist
|
|||||
Last
2.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.82M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 193170 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 70000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 193170 | 0.029 |
2 | 450000 | 0.028 |
1 | 100000 | 0.027 |
2 | 164000 | 0.026 |
1 | 20020 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 70000 | 1 |
0.033 | 112500 | 1 |
0.035 | 526666 | 3 |
0.036 | 237449 | 2 |
0.038 | 78888 | 1 |
Last trade - 16.14pm 07/08/2024 (20 minute delay) ? |
Featured News
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
DVP
Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place
NEWS
Is oil undervalued?
DNA (ASX) Chart |
Day chart unavailable